Cold agglutinin disease secondary to severe SARS-CoV-2 treated with eculizumab.
BMJ Case Rep
; 15(4)2022 Apr 29.
Article
in En
| MEDLINE
| ID: mdl-35487646
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Anemia, Hemolytic, Autoimmune
Type of study:
Etiology_studies
Limits:
Humans
Language:
En
Journal:
BMJ Case Rep
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: